The Latest Breaking News from TMDX

These three small stocks carry significant risk, but that volatility has served traders well this year; now it's time for long-term investors to take a look

Several mid-cap medical stocks, such as ADMA, PEN, and TMDX, are outperforming in 2025, showing resilience despite broader market weakness.

TransMedics Group Inc (NASDAQ:TMDX) shares got a massive boost after better than expected Q1 earnings and 2022 guidance. The company posted an EPS loss of $(0.38) in line with expectations and higher than $(0.29) a year ago despite more than doubling its sales from Q1 FY21. Net revenue of $15.9 million increased 125%…

Although the healthcare industry has been flourishing since the onset of the COVID-19 pandemic, driven in-part by substantial demand owing to an aging population and increasing chronic diseases, there are a few healthcare stocks with stretched valuations and poor growth prospects. Among such stocks are iRhythm (IRTC), TransMedics (TMDX), and…